Cardiff Biologicals

Cardiff Biologicals Limited is a biotechnology company based in Cardiff, Wales, specializing in the discovery and development of novel oncology therapeutics. Spun out from Cardiff University to commercialize the research of Professors Chris McGuigan and Wen Jiang, the company focuses on anti-angiogenesis products and bioinformatics-driven drug discovery. In 2007, it was acquired by Morvus Technology Limited, which integrated its drug development expertise and bioinformatics database into its broader oncology portfolio. Its research has contributed to the development of therapeutic candidates targeting hepatocyte growth factor activator inhibitors and diagnostic methods for breast cancer prognosis. The company remains an active legal entity and subsidiary of Morvus Technology, supporting the advancement of specialized cancer treatments.